Giant rapidly involuting congenital hemangioma in a neonate: a case report
By
Jian Pang
Yulan Pang
Yanni Tang
Pingping Liu
Shuihua Yang
May 29, 2026
Clinical Scorecard: Giant Rapidly Involuting Congenital Hemangioma in a Newborn: A Case Study
At a Glance
Category Detail
Condition Giant Rapidly Involuting Congenital Hemangioma (RICH) Key Mechanisms Benign vascular tumor that undergoes spontaneous involution Target Population Neonates Care Setting Pediatric care, neonatal intensive care
Key Highlights
Prenatal ultrasound identified a placenta-like lesion on the right lower limb. Massive dark purple tumor observed postnatally, confirmed as RICH with no deep tissue involvement. Complete spontaneous involution within the first year of life without intervention. Transient thrombocytosis and ulceration occurred during regression. Importance of recognizing clinical and radiological features to avoid unnecessary treatments. Guideline-Based Recommendations
Diagnosis
Utilize prenatal ultrasound for early identification of congenital hemangiomas. Confirm diagnosis with imaging modalities such as ultrasound or CT. Management
Adopt an active observation strategy for RICH lesions. Manage ulceration with wound care and infection surveillance. Monitoring & Follow-up
Regular clinical follow-up to assess lesion size and monitor for complications. Risks
Potential complications include high-output cardiac failure and consumptive coagulopathy. Patient & Prescribing Data
Neonates with giant RICH lesions
Conservative management with emphasis on wound care and monitoring.
Clinical Best Practices
Educate parents on the expected natural history of RICH. Use low-dose imaging protocols to minimize radiation exposure in neonates. Related Resources & Content
